Views | |
---|---|
MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial | 78 |
marca 2023 | kwietnia 2023 | maja 2023 | czerwca 2023 | lipca 2023 | sierpnia 2023 | września 2023 | |
---|---|---|---|---|---|---|---|
MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial | 5 | 0 | 0 | 0 | 1 | 1 | 2 |
Views | |
---|---|
korkosz_et-al_mor103_a_human_monoclonal_antibody_2015.pdf | 100 |
korkosz_et-al_mor103_a_human_monoclonal_antibody_2015.odt | 6 |
Views | |
---|---|
United States | 48 |
Poland | 11 |
Germany | 3 |
Ireland | 2 |
Bulgaria | 1 |
Brazil | 1 |
China | 1 |
Netherlands | 1 |
Views | |
---|---|
Ashburn | 24 |
Chandler | 7 |
Polska | 7 |
Des Moines | 2 |
Dublin | 2 |
Wroclaw | 2 |
Beijing | 1 |
Burgas | 1 |
Cambridge | 1 |
Fairfield | 1 |